Stuttering, Adult
16
7
8
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 16 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (16)
Using Transcranial Magnetic Stimulation to Treat Stuttering
Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder
Speech Processing in Stuttering
Effects of Altered Auditory Feedback on Speech Fluency
Organization and Development of Motor Cortical Circuits for Speech Production in Stuttering
Bihemispheric Transcranial Direct Current Stimulation* on Speech Fluency
Dopamine and Sensorimotor Function in Stuttering
Transcranial Alternating Current Stimulation (tACS) in Stuttering
Investigating the SMA's Role in Speech and Reading Fluency in PWS With rTMS
Information Processing Biases in Adults Who Stutter
Effects of Al-Lisaan Urdu Digital Software for Self-Assessment and Treatment of Adult Stutters
High-definition tDCS Treatment for Cantonese-speaking Adults Who Stutter
Exploring the Nature, Assessment and Treatment of Stuttering
The Effects of Brain Stimulation on Speech Fluency in Adults Who Stutter
Study of the Effect of the Auditory Stimulation on Stuttering Symptoms in Patients With a Deficit of Spectral Power in the EEG Beta Frequency Band
Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).